Have a Claim?

Click here for a confidential contact or call:


February 6, 2015

Posted  January 25, 2016

Oregon-based drug maker James G. Cole Inc., and its president James G. Cole and former general manager Julie D. Graves, have been permanently enjoined from selling their products which are distributed under the name “Maxam Nutraceutics.” According to the government, the company’s products are unapproved, misbranded and manufactured under conditions that are inadequate to ensure their quality. The court based its decision in part on the company’s claims the products could treat autism, Alzheimer’s, HIV and Fibromyalgia, among other diseases. DOJ